Sreoshi Chatterjee 452 posts 0 comments

Shiseido Company asserted that it has obtained Olivo Laboratories. Olivo is mainly a Polaris partners- based startup advancing the dermatological field through proprietary biomaterials…
Read More...

It is noteworthy that Ligand Pharmaceuticals entered into license agreement with Glenmark Pharmaceuticals to use Ligand's OmniAb platform including Omnichicken, Omnirat, OmniMouse and…
Read More...

Sarah Cannon entitled Johanna C. Bendell, MD, to Chief Development Officer. Her responsibilities encompass developing and expanding physician, site and Pharma relationships across the…
Read More...

In a bid to offer qualitative radiation therapy and cancer care services, Alliance healthcare services ventures into a stock purchasing agreement with e+CancerCare in order to function…
Read More...

SkinCure Oncology declared delivery of its  46th image guided superficial radiation therapy system. SkinCure Oncology is into providing a turnkey model for delivery of such systems.…
Read More...

LivaNova PLC commences its enrollement of patients in the Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-Surgical Aortic Valve Implant Study (“BELIEVE”).  A trial…
Read More...

Boston Scientific Corporation asserted the successful approval of its Spectra Wavewriter Spinal Cord System by U.S FDA to met out paresthesia – based and sub- perception therapy…
Read More...

This is to be brought to notice that WaveForm Technologies has successfully completed its four clinical Trials for its proprietary continuous glucose monitoring system. Patients are…
Read More...

The Medical Ethical Review Committee sought the Xcede Patch clinical trial dossier to initiate first-in-human clinical trial that eyes the treatment of up to 30 patients encountering…
Read More...

Target PharmaSolutions asserts that Novartis has entered into strategic alliance for TARGET-NASH. TARGET-NASH is a longitudinal observational study that assesses adult and pediatric…
Read More...